Nu-Med Plus raises $450,000 in preferred stock private placement
NUMD•Nu-Med Plus raised $450,000 from two accredited investors in a private placement on October 19, 2026. Investors bought 171,232 Series A preferred shares at $2.628 each; a consultant received another 50,000 shares for services.
1. Placement details
Nu-Med Plus raised $450,000 from two accredited investors in a private placement on October 19, 2026. The investors purchased 171,232 unregistered Series A preferred shares at $2.628 per share, and a consultant received 50,000 unregistered Series A preferred shares for services rendered that day. Full conversion would yield 3,424,640 common shares for the investors and 1,000,000 common shares for the consultant, excluding beneficial ownership limits; conversion ratios will not adjust for future reverse stock splits.
